HopSo Tablet 400 mg contains Sofosbuvir, a direct-acting antiviral (DAA) used for the treatment of chronic hepatitis C virus (HCV) infection. Sofosbuvir works by inhibiting the NS5B polymerase enzyme, which is essential for HCV replication. By blocking this enzyme, Sofosbuvir prevents the virus from multiplying, allowing the body’s immune system to clear the infection effectively.

HopSo is a key component in modern hepatitis C therapy and is often used in combination with other antivirals, such as Velpatasvir or Ledipasvir, to enhance treatment efficacy. Its oral tablet form makes administration simple and convenient, supporting adherence to therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

HopSo Tablet 400 mg is indicated for:

• Chronic hepatitis C virus (HCV) infection in adults

• HCV genotypes 1–6, often used as part of combination therapy with other antivirals

• Patients with compensated liver disease or cirrhosis, depending on medical guidance

• Individuals seeking interferon-free therapy for safer and more tolerable treatment

• Treatment of HCV in patients co-infected with HIV, under specialist supervision

Sofosbuvir has been shown to achieve high rates of sustained virologic response (SVR), essentially curing HCV in most patients when used according to recommended protocols.

Dosage and Administration

• Adults: 400 mg once daily, with or without food, as prescribed by a healthcare professional

• Typically prescribed for 12–24 weeks, depending on HCV genotype, liver condition, and co-administered antivirals

• Combination therapy with other DAAs or ribavirin may be required for certain patient groups

• Adherence to daily dosing is critical to prevent treatment failure or viral resistance

• Do not alter dosage or stop therapy without consulting a healthcare professional

Benefits

• Directly inhibits HCV replication, targeting the virus at the molecular level

• Highly effective across multiple HCV genotypes, often achieving cure rates above 90%

• Oral administration is simple, improving patient compliance

• Interferon-free therapy reduces side effects compared to older treatments

• Can be used safely in combination with other antivirals to enhance cure rates

• Improves liver function, reduces inflammation, and lowers the risk of liver cirrhosis or hepatocellular carcinoma

Side Effects

HopSo Tablet is generally well tolerated. Possible side effects may include:

• Fatigue, headache, nausea, or insomnia

• Mild anemia or dizziness when used with ribavirin

• Rare allergic reactions: rash, itching, or swelling

Serious side effects are uncommon. Any persistent or severe symptoms should be reported to a healthcare provider immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Not recommended for patients with severe liver impairment without medical supervision

• Pregnant or breastfeeding women should use only under specialist guidance

• Inform the healthcare provider of other medications, including HIV antivirals, to avoid interactions

• Regular liver function tests and viral load monitoring are recommended during therapy

• Patients should avoid alcohol and hepatotoxic drugs during treatment

Storage

Store in a cool, dry place below 30°C, protected from moisture and sunlight. Keep out of reach of children.

HopSo Tablet 400 mg (Sofosbuvir) is a highly effective antiviral therapy for hepatitis C, providing safe, convenient, and targeted treatment to achieve viral clearance and protect liver health under proper medical supervision.